GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (NAS:POAI) » Definitions » Shiller PE Ratio

Predictive Oncology (Predictive Oncology) Shiller PE Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Predictive Oncology Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Predictive Oncology Shiller PE Ratio Historical Data

The historical data trend for Predictive Oncology's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Shiller PE Ratio Chart

Predictive Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Predictive Oncology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Predictive Oncology's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Predictive Oncology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Oncology's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Predictive Oncology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Predictive Oncology's Shiller PE Ratio falls into.



Predictive Oncology Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Predictive Oncology's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Predictive Oncology's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.85/129.4194*129.4194
=-0.850

Current CPI (Dec. 2023) = 129.4194.

Predictive Oncology Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -2,731.410 99.695 -3,545.807
201406 -2,922.480 100.560 -3,761.212
201409 -1,861.800 100.428 -2,399.266
201412 -3,827.500 99.070 -5,000.043
201503 -359.546 99.621 -467.092
201506 -1,790.520 100.684 -2,301.540
201509 -1,073.460 100.392 -1,383.848
201512 -2,173.880 99.792 -2,819.275
201603 -602.000 100.470 -775.457
201606 -190.000 101.688 -241.815
201609 -64.000 101.861 -81.315
201612 -32.108 101.863 -40.794
201703 -42.000 102.862 -52.844
201706 -82.000 103.349 -102.685
201709 -32.000 104.136 -39.770
201712 -32.000 104.011 -39.817
201803 -30.000 105.290 -36.875
201806 -40.000 106.317 -48.692
201809 -37.800 106.507 -45.932
201812 -48.400 105.998 -59.095
201903 -41.800 107.251 -50.440
201906 4.800 108.070 5.748
201909 -26.200 108.329 -31.301
201912 -90.800 108.420 -108.387
202003 -18.600 108.902 -22.104
202006 -7.200 108.767 -8.567
202009 -9.200 109.815 -10.842
202012 -11.583 109.897 -13.641
202103 -2.200 111.754 -2.548
202106 -1.000 114.631 -1.129
202109 -1.600 115.734 -1.789
202112 -2.600 117.630 -2.861
202203 -1.020 121.301 -1.088
202206 -2.890 125.017 -2.992
202209 -1.040 125.227 -1.075
202212 -2.030 125.222 -2.098
202303 -0.860 127.348 -0.874
202306 -0.980 128.729 -0.985
202309 -0.780 129.860 -0.777
202312 -0.850 129.419 -0.850

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Predictive Oncology  (NAS:POAI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Predictive Oncology Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Oncology (Predictive Oncology) Business Description

Traded in Other Exchanges
N/A
Address
2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.
Executives
Robert L Myers officer: CHIEF FINANCIAL OFFICER 4765 BEACON HILL ROAD, EAGAN MN 55122
Nuzum Charles Lee Sr director 633 1ST STREET WEST, SONOMA CA 95476
Veena Rao director 2915 COMMERS DRIVE, SUITE 900, EAGAN MN 55121
Matthew Hawryluk director C/O GRITSTONE ONCOLOGY, INC., 5858 HORTON STREET, SUITE 210, EMERYVILLE CA 94608
St. Clair Gregory Sr director 1645 WHITLEY DRIVE, HARRISBURG PA 17111
Nancy Chung-welch director P O BOX 1572, PEPPERELL MA 01463
Pamela Bush officer: Chief Business Officer 2915 COMMERS DRIVE, SUITE 900, EAGAN MN 55121
Daniel E Handley director 1142 S. DIAMOND BAR BLVD. #464, DIAMOND BAR CA 91765
Raymond F Vennare director 2915 COMMERS DRIVE, SUITE 900, EAGAN MN 55121
David Stewart Smith director 151 WASHINGTON STREET, PITTSBURGH PA 15218
J Melville Engle director 1 REMINGTON COURT, NAPA CA 94558
Jenkins Christina Lee Md director 2915 COMMERS DRIVE, SUITE 900, EAGAN MN 55121
Carl I. Schwartz 10 percent owner 20155 N.E. 38TH COURT, UNIT 3104, AVENTURA FL 33180
Richard L Gabriel director 900 COCOANUT AVENUE, SARASOTA FL 34236
Pamela S Prior director 2915 COMMERS DRIVE, SUITE 900, EAGAN MN 55121

Predictive Oncology (Predictive Oncology) Headlines